Y. Maeda et al., ELEVATED LEVELS OF SOLUBLE ICAM-1 IN SERUM OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA UNDERGOING BONE-MARROW TRANSPLANTATION, American journal of hematology, 52(3), 1996, pp. 227-228
Serum soluble ICAM-1 concentrations were measured in 10 patients with
or without chronic graft-vs.-host disease (GVHD) after allogeneic bone
marrow transplantation. The serum soluble ICAM-1 levels in the patien
ts with chronic GVHD were significantly higher than that in the patien
ts without chronic GVHD, The data indicated that serum soluble ICAM-1
is a useful parameter for predicting chronic GVHD. (C) 1996 Wiley-Liss
, Inc.